The UCSF School of Pharmacy has entered into a five-year collaborative education and research agreement with Tsinghua University School of Medicine in Beijing, China.
The agreement will establish a joint Tsinghua School of Medicine-UCSF School of Pharmacy program for pharmacology and pharmaceutical sciences education and research at Tsinghua University, which is one of China’s top science and engineering schools.
Observations and actions: First 100 days, Accreditation review of the PharmD program (Assemi), Recently received research funding (Phillips, Gartner, Abate), Recent faculty publications (Wells, DeGrado, González Burchard, Shin), Research in the public eye (Roy, González Burchard), Honors (Ahituv, Hernandez), Patient care (Tobacco, SB 493), New faculty members (Fraser, Bandyopadhyay, Pon, Gestwicki), New role for Brian Alldredge, Faculty retirements (Alsop, Soller, Leeds, Oppenheimer), more.
Zev Gartner, PhD, has been named a recipient of the 2013 National Institutes of Health (NIH) Director’s New Innovator Award, which will provide his lab with up to $1.5 million in research funding over the next five years.
Research led by UCSF scientists has provided fresh insight into the operation of DNA sequences in the genome that regulate gene expression.
The new study looked at the effects of inserting nearly 5,000 synthetic regulatory element sequences into mice as well as human liver cells. Specifically, these were enhancers, snippets of DNA which, when bound by protein molecules called transcription factors, contribute to gene activation.
In the largest study of its kind to date, researchers led by UCSF scientists found that infants in minority populations who are exposed to motor vehicle air pollution, specifically nitrogen dioxide (NO2), are more likely to develop asthma later in childhood.
The San Francisco Chronicle and the Bay Area News Group, which includes the San Jose Mercury News and Oakland Tribune, have published feature articles this week focused on The Kidney Project, an effort to develop the first implantable bioartificial kidney to treat end-stage renal disease.
A new video produced by the American Museum of Natural History features the work of Esteban Burchard, MD, MPH, and members of his laboratory.
“Genes and Health: Moving Beyond Race,” shows how Burchard’s lab is using differences in the ancestry of asthma patients to help find genetic variations contributing to the disorder, the most common chronic disease in children.
B. Joseph Guglielmo, PharmD, an honored UCSF professor and mentor as well as a leading pharmacist and clinical scientist specializing in antimicrobial therapies, will be the new dean of the UCSF School of Pharmacy.
His appointment, officially announced today by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, after being approved by UC President Mark Yudof, will take effect April 1.
Physicist Adam Abate, PhD, who applies microfluidics technology to speedily process millions of encapsulated biological samples to discover drugs, engineer proteins, and diagnose cancers, has received a National Science Foundation (NSF) CAREER award.
Ryan Hernandez, PhD, whose lab studies patterns of genetic variation from populations around the world, using detailed computer modeling to learn more about human evolutionary processes and to discover regions of the genome vital to function and underlying disease, has been named a 2013 Alfred P. Sloan Research Fellow.
During his illustrious half-century career, UCSF School of Pharmacy faculty member Leslie Benet, PhD, has authored more than 400 peer-reviewed publications, many helping to define the field of pharmacokinetics—how the body absorbs, distributes, metabolizes, and excretes medications—or as he once put it, “what the body does to the drug.”
Top NIH funding: Shu, Aweeka, Brodsky. Recent gifts to The Kidney Project. Honors and awards: Day, Youmans, Benet, Schoenhaus. New pharmacy care model, Safeway. John Craig remembered. Mary Anne Koda-Kimble celebrated. Achieving our vision: 2007-2012.
Research at the UCSF School of Pharmacy to develop the first implantable bioartificial kidney recently received exceptional private support: $1 million from the family of the late philanthropists Harry and Diana Hind, and $50,000 from the Patterson Barclay Memorial Foundation.
